Urinary frequency, nocturia, weak stream, or urine retention Urological and Genital Diseases
Conditions
Interventions
We prospectively collected and analyzed data from 29 patients who underwent vapoenucleation of the prostate (ThuVEP) between August 2010 and May 2012. The control group included 30 patients who underw
Sponsors
Taipei Veterans General Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. International prostate symptom score (IPSS) >7 2. Maximum urinary flow rate (Qmax) <15 mL/s 3. Normal level of age-specific prostate-specific antigen (PSA) 4. Patients with abnormal levels of age-specific PSA or positive findings on digital rectal examination underwent transrectal ultrasonography (TRUS)-guided biopsy to rule out prostate cancer. Ten patients underwent TRUS-guided biopsy before the operation
Exclusion criteria
Exclusion criteria: Prostate cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Operative variables obtained before the operation 2. Patient profiles obtained before the operation 3. Urine flow rates obtained before the operation and at 3, 6, 9 and 12 months after the operation 4. Prostate volume (measured using transrectal ultrasonography) obtained before the operation and at 3, 6, 9 and 12 months after the operation 5. International prostate symptom score (IPSS) via questionnaires obtained before the operation and at 3, 6, 9 and 12 months after the operation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Urine flow rates obtained at 6, 9 and 12 months after the operation 2. Prostate volume (measured using transrectal ultrasonography) obtained at 6, 9 and 12 months after the operation 3. International prostate symptom score (IPSS) via questionnaires obtained at 6, 9 and 12 months after the operation | — |
Countries
Taiwan
Outcome results
None listed